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Introduction
In the world, about 400 million people complained about 
cancer or other bladder disease (Atala 2000). Treat-
ments for bladder cancer are partial resection of the blad-
der wall, immunotherapy, chemotherapy, and radiation 
(Pattison et al. 2005). In recent years, enterocystoplasty has 
become a frequently used technique amongst aforementioned 
bladder cancer treatments. Enterocystoplasty is a bladder 
reconstruction procedure using natural tissue. In this tech-
nique, a portion of intestine is placed on the bladder mucosa. 
This surgical reconstruction was used to increase the bladder 
capacity and reduce the amount of pressure on the bladder 
wall. But, enterocystoplasty has many disadvantages such as 
transplant area perforation, infections, metabolic diseases, 
and excessive mucus production (Eberli 2010). Based on 
these problems, tissue engineering has been used for bladder 
reconstruction as a promising approach for several years. Tis-
sue engineering is a multidisciplinary field involving biology, 
medicine, and engineering for replacing compromised or lost 
tissue and organ functions (Langer and Vacanti 1993, Persidis 
1999). Scaffolds prepared via tissue engineering approach 
plays important role for bladder disease treatment, which 
have adjustable properties such as mechanical, elasticity, 
and biocompatibility. Polymeric biomaterials in the bladder 
replacement have been promising repair materials. In the 
bladder reconstruction as biologically derived materials used 
bladder acellular matrix, small intestinal submucosa (Zhang 
et al. 2000, 2004), as synthetic polymeric materials used such 
as poly(glycolic acid) (PGA), Poly(lactic-co-glycolic acid), poly-
L-lactic acid, poly-e-caprolactone and polyurethane (Mooney 
et al. 1996, Mikos et al. 1994). Poly(hydroxyalkanoate)s [P(HA)
s], a family of microbial-derived polyesters, produced by a vari-
ety of bacteria and have been widely used for biomedical appli-
cations (Chen and Wu 2005, Lenz and Marchessault 2005). 
Among them, in the last decades, PHB was used as attractive 
material in tissue engineering application because of its com-
patibility in contact with tissue and blood and nontoxic prop-
erties (Gogolewski et al. 1993, Clarotti et al. 1992). Further, its 
degradation product, 3-hydroxybutyric acid, is found naturally 
in human blood (Lee 1996). Recently, a wide variety of research 
studies is based on the behavior of bladder cells on the PHA-
derived scaffolds. Renard et al. (2011) investigated the effect of 
chemical structure of PHAs modified with poly(ethyleneglycol) 
PEG on the adhesion and proliferation of human bladder car-
cinoma RT112 cells. On other hand, Garcia et al. found that 
poly(3-hydroxybutyrate-co-3-hydroxyvalerate) [P(HB-co-HV)] 
functionalized with a laminin-derived YIGSR sequence clearly 
enhanced the adhesion of urothelial cells. (García-García et al. 
2012). These report showed that PHB is a potential biomaterial 
to be used in bladder tissue engineering applications and there 
are limited studies related to its use in this field.
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Abstract
The aim of the study is in vitro investigation of the feasibility 
of surface-modified bacterial nanofibrous poly [(R)-3-
hydroxybutyrate] (PHB) graft for bladder reconstruction. 
In this study, the surface of electrospun bacterial PHB was 
modified with PEG- or EDA via radio frequency glow discharge 
method. After plasma modification, contact angle of EDA-
modified PHB scaffolds decreased from 110  1.50 to 23  0.5 
degree. Interestingly, less calcium oxalate stone deposition 
was observed on modified PHB scaffolds compared to that of 
non-modified group. Results of this study show that surface-
modified scaffolds not only inhibited calcium oxalate growth but 
also enhanced the uroepithelial cell viability and proliferation.
Keywords:  bladder reconstruction, calcium oxalate stones, 
nanotexture, poly [(R)-3-hydroxybutyrate] (PHB),  
tissue engineering
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Surface properties of medically used biomaterials have a 
considerable influence on the acceleration of tissue regen-
eration (Mooney et al. 1996). In previous studies, the effect of 
nanoscale surface features created through chemical etching 
compared with conventional form had examined on the cell 
density, inhibition of calcium stone formation, and bladder tis-
sue regeneration capability (Chun et al. 2009). The published 
results demonstrated that nanotextured surfaces increase 
the adsorption and bioactivities of adhesive proteins such 
as fibronectin and vitronectin (Khang et al. 2007, Miller et al. 
2005). The nanoscale rough polymeric materials promote the 
cellular adhesion, proliferation, and extracellular matrix syn-
thesis in bone, cartilage, vascular, and bladder tissue (Ratner 
et al. 2004). In addition to that, it has been shown that these 
materials inhibited calcium oxalate stone formation owing to 
surface properties (Chun et al. 2009, 2010). Electrospinning, 
which is a frequently used nanofabrication system in tissue 
engineering applications, can mimic the collagen fibers on the 
native extracellular matrix (Li et al. 2002). The previous stud-
ies reported that nanofibrillar scaffolds showed better perfor-
mance related to the cytoskeletal alignment of adherent cells 
and cellular phenotype expression compared to conventional 
microfiber structures (Harrington et al. 2008). In another study, 
Harrington and colleagues have modified the surface of fiber-
bonded poly(glycolic acid) (PGA) scaffolds using branched 
peptide-amphiphile (b-PA) molecules containing cell-adhesive 
RGDS. Primary human bladder smooth muscle cells showed 
greater initial adhesion to b-PA-modified scaffolds than to 
uncoated PGA scaffolds (Harrington et al. 2006). Further, Baker 
et al. also demonstrated that argon plasma of electrospun poly-
styrene nanofiber scaffolds significantly enhanced smooth 
muscle cell attachment. Electrospun polymer nanofibers have 
been widely used in bladder tissue engineering owing to theirs 
tendency to mimic nanostructured bladder ECM (Baker et al. 
2006). The data suggest that electrospinning may be useful pro-
cess for promoting of mouse bladder epithelial cells.
For these reasons, the purpose of this study was to pro-
duce surface properties-enhanced electrospun bacterial 
PHB scaffolds which could be used for partial reconstruction 
of the bladder. We first characterized synthesized PHB using 
Differential Scanning Calorimetry (DSC) and then viscosim-
etric molecular weight was determined. In a first stage, the 
surface of nanofibrous PHB scaffolds were functionalized 
with different charged polymers such as EDA and PEG. These 
modified scaffolds were characterized using scanning elec-
tron microscopy (SEM), contact angle measurement, and 
X-ray photoelectron spectroscopy (XPS) to assess the surface 
topography, wettability, and surface chemistry, respectively. 
Using mouse bladder epithelial cells, the effect of plasma 
treatment on uroepithelial cell attachment and proliferation, 
and the stone formation were determined using a modified 
3-[4,5-dimethyl(thiazol-2yl)-3,5-diphery] tetrazolium bro-
mide (MTT) assay and Alizarin Red-S staining, respectively.
Materials and methods
Materials
Poly [(R)-3-hydroxybutyrate], (PHB) and ethylenediamine 
(EDA) were obtained from Fluka (Switzerland). The average 
molecular weight (Mw) for used commercial PHB to compare 
with our synthesized bacterial PHB was 540,000 g/mol. Chlo-
roform was used as a solvent and obtained from Sigma (USA). 
Polyethylene glycol, PEG (Acros, Belgium, Mw  300 Da), and 
EDA were used for the modification of PHB scaffolds.
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl tetrazolium 
bromide (MTT) was purchased from Aldrich (USA). Mouse 
urinary bladder cells were maintained in Dulbecco Modified 
Eagle’s Medium (DMEM)/Ham’s F10 (1:1) supplemented with 
fetal bovine serum (FBS) and 1% penicillin/streptomycin (Bio-
logical Industries, Israel), 10 mg/ml insulin (Sigma), 5 mg/ml 
transferrin (Gibco/BRL, France), 5 ng/ml selenite F (Gibco/
BRL, France), 10 mM HEPES, and 50 nM hydrocortisone.
Bacterial PHB production and characterization
Alcaligenes eutrophus was used for bacterial PHB produc-
tion as reported in our previous study. (Karahaliloğlu et al. 
2012). Cells were first grown in 250 ml containing 50 ml of 
nitrogen-rich medium for 24 h, which contains 10 g/l glucose, 
2 g/l yeast extract, 2 g/l pepton, 1 g/l K2HPO4, 1 g/l KH2PO4, 
1 g/l (NH4)SO4, and 0.05 g/l MgSO4.7H2O. Bacteria were 
collected via centrifugation and suspended in the medium. 
The medium contains (per liter): sucrose 20 g, KH2PO4  
1.5 g, Na2PO4 3 g, MgSO4 0.2 g, CaCl22H2O 0.01 g, and 1 ml 
of trace element solution. Trace element solution contains 
(per liter): FeSO4.7H2O 2 g, H3PO4 0.3 g, CoCl26H2O 0.2 g, 
ZnSO47H2O 0.03, MnCl2.4H2O 0.03 g, (NH4)6Mo7O244H2O 
0.03 g, NiSO47H2O 0.03 g, and CuSO45H2O 0.01 g. The bacteria 
were cultivated at 150 rpm and 30°C for 48 h. After cultivation, 
cell broth was centrifuged at 4,000  g for 10 min, washed twice 
with distilled water, and then stored at  80°C for overnight. 
Bacterial PHB containing biomass was suspended in 5 ml of 
sodium-hypochlorite solution for 24 h 37°C. The solution was 
centrifuged twice and supernatant was removed. Bacterial 
PHB containing cell debris was washed with distilled water 
and the biomass was mixed with 5 ml chloroform for 1 h at 
37°C. The clear polymer solution was recovered via centrifu-
gation to remove the majority of the non-PHB cell material.
As can be seen in previous published work, bacterial 
PHB was characterized using Nuclear Magnetic Resonance 
and Fourier Transform Infrared and obtained high purity 
polymer. In this study, the thermal properties of synthesized 
polymer were characterized using a Mettler Toledo DSC-1. 
DSC analysis was performed under nitrogen atmosphere 
from 25 to 220°C at a heating rate of 10°C/min. The crys-
tallinity percent of bacterial PHB was calculated from DSC 
results using the following equation.
X % H100/ Hc 0( ) ∆ ∆
where ΔH0 described melting enthalpy of 100% crystalline 
PHB that the value assumed to be 146 J/g in the literature 
(Gogolewski et al. 1993, Li et al. 2003, Barham et al. 1984). 
ΔH is the melting enthalpy of the sample.
Viscosimetric molecular weight of bacterial PHB was 
measured using Ubbelohde capillary viscometer at 25°C in 
a thermostat bath. Firstly, PHB was dissolved in chloroform 
at different concentrations and efflux times of the polymers 
were measured using the serial dilution technique. The rela-
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tive viscosity (hr) of polymer was calculated using of hr   t/t0 
equation according to the flow time of polymer and solvent. 
Specific viscosity was calculated using following equation
η ηsp r 0 01 t t /t   ( )  (Cincu et al. 2000)
From the specific viscosity value (hsp) of polymer intrinsic 
viscosity was calculated.
η η ηsp
2 2c k c [ ] [ ]
Viscosimetric molecular weight (Mv) of bacterial PHB 
polymer was calculated directly according to Mark– 
Houwink–Sakurada equation, where K and a are constants.
η α[ ]K Mv  (Ichikawa et al. 1995)
Urinary bladder matrix preparation using  
electrospinning
Five percent weight of PHB solutions was prepared by dissolv-
ing in CHCl3/ethanol solutions (3:1 v/v) overnight. In the study, 
a high-voltage power supply (Spellman CZE1000R) was used for 
the production of nanofiber. Systems parameters are 5% poly-
mer concentration, 17 kV voltages, the distance between the tip 
of the syringe and collector is 15 cm, and 2 ml/h flow rate.
Plasma modifications of bacterial PHB nanofibrillar scaffolds
PHB scaffolds were modified by plasma for alteration of 
the scaffold surface chemistry, that is, to increase the cell 
attachment and growth. Plasma was processed in a stain-
less steel parallel-plate plasma reactor using PEG and EDA 
monomers. Plasma modification system (Vacuum, Praha) 
was equipped with radio frequency (RF, 13.56 MHz) glow 
discharges generator and it was attached to a vacuum pump 
for maintaining the vacuum inside the chamber. Before 
the plasma process, PHB scaffolds were cut into a size of 
1  1 cm and positioned on the grounded electrode with 
exposing the sample to plasma glow. As a first, argon gas was 
passed through the reactor at 0.1 m bar pressure in order to 
remove reactive species like oxygen and nitrogen. Then, the 
reactor was fed with PEG and EDA, respectively, and the glow 
discharge initiated at power of 35 W for 20 min. The argon 
gas was passed through the chamber again to sweep away 
any gaseous residue. The scaffolds were kept in vacuum for 
10 min for the stabilization of modification.
Contact angle measurement
The wettability of modified and non-modified bacterial PHB 
surfaces was evaluated using contact angle measurements 
(DSA100, KRUSS, Germany). The samples were cut into 
0.5 cm  0.5 cm (length  width) for the analysis. Deionized 
water was dropped on the PHB samples through the micro 
syringe at room temperature. Average static contact angles 
and its standard deviation of non-modified and modified 
PHB scaffolds were calculated by obtaining five measure-
ments from different parts of the samples.
In-vitro degradation
Samples were cut into small pieces 0.5 cm  0.5 cm and 
weighed (W0). The mass loss rate of the sample was 
determined by immersing into phosphate buffer saline (PBS 
pH: 7.4). The samples were placed in 5 mL of PBS solutions 
(pH 7.4) and incubated for 1, 2, 3, 4, and 5 weeks at 37°C. 
Every week samples were removed from solutions, washed 
with distilled water, lyophilized for 3 h and weighed (Wt). 
PBS solution was replaced with new solution each week.
Degradation W W Wt% /( ) ( )   0 100
Calcium stone synthesis
For the calcium stone synthesis, 0.5 g CaCl2 was placed in a 
250 ml dry beaker and 10 ml of 6 M HCl was added slowly 
to this solution. The erlenmeyer was covered with a watch 
glass. After the dissolution completed, the solution was 
diluted with 150 mL deionized water. This aqueous solution 
was heated to boil in the fume hood. 5 g ammonium oxalate 
was dissolved in 50 ml water and heated to dissolve the 
salt completely. Ammonium oxalate solutions were added 
to the hot calcium chloride solutions. A few drops of NH3 
were added until a precipitation occurs. The precipitate was 
removed with a filter paper and dried.
Calcium deposition on the scaffold
Calcium deposition on the PHB scaffolds was examined by 
Alizarin Red-S staining. PHB scaffolds were cut into 0.5  0.5 
cm in square shape. 0.013 g of synthesized oxalate was dis-
persed in 10 ml of distilled water. PHB scaffolds were placed 
in 1 ml of oxalate solutions on 1st, 3rd, 5th and 7th days. At 
the end of each day, the scaffolds were removed and fixed with 
cold methanol solutions for 10 min. All samples were washed 
twice with distilled water and immersed in 200 ml Alizarin 
Red-S solutions (in a mixture of ammonium hydroxide/water; 
1:100, pH: 4.1–4.3) for 3 min. For the destaining, cetylpyridin-
ium chloride monohydrate solution, which was prepared at 
10% concentration in 10 mM sodium phosphate at room tem-
perature, was used. These samples were placed in this solution 
for 15 min and spectrophotometrically read at 570 nm.
XPS analysis
XPS (Thermo Scientific K-Alpha, USA) was used to analyze 
the surface chemistry of bacterial PHB scaffolds before and 
after calcium oxalate treatment. Each of the 0.5  0.5 cm-
sized samples was placed in tubes containing 0.13% calcium 
oxalate solution. Calcium amount on the scaffolds was mon-
itored after 1, 3, 5, and 7 days. The scaffolds were irradiated 
with a monochromatized Al Ka X-ray source (1486,6 eV). The 
pass energy of the analyzer was 50 eV for high-resolution 
core level spectra and the beam spot was 400 mm. Curve fit-
ting of the spectra was performed with the Thermo Avantage 
v4.41 Software. A Shirley-type correction was applied to the 
background under all fitted peaks.
In-vitro cell proliferation
In-vitro cell proliferation on the PHB scaffolds was observed 
using colorimetric MTT (a yellow tetrazole) assay. Mouse 
urinary bladder cell line (Foot and Mouth Diseases Institute, 
Ankara-Turkey) were cultured in a mixture of DMEM and 
Ham’s F10 (1:1) supplemented with 10% FBS and 1% penicil-
lin/streptomycin, 10 mg/ml insulin, 5 mg/ml transferrin, 5 
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h and immersed in a series of ethanol solutions (25, 50, 
75, 90 and 100%), respectively, then the samples were 
dehydrated with hexamethyldisilazane. After drying, the 
samples were coated with gold/palladium mixture for SEM 
examination.
Statistical analysis
All data values were studied least as in triplicate and pre-
sented as mean  standard deviation. Statistical analyses 
were carried out using PASW Statistics version 18. Significant 
differences between groups were performed by Scheffe’s 
test and p  0.05 was considered as statistically significant.
Results
Characterization of bacterial PHB
The DSC thermogram of the bacterial PHB is presented 
in Figure 1. Bacterial PHB showed a crystallization peak 
ng/ml selenite F, 10 mM HEPES, 50 nM hydrocortisone. PHB 
scaffolds (1  1 cm) were placed in a 24-well culture plate. The 
scaffolds were sterilized by immersion in 70% EtOH for 5 min, 
and then washed twice with culture medium. After the reach 
to 80% confluence, the uroepithelial cells were detached by 
trypsin-EDTA and counted with hemocytometer. 1  103 cells 
were pipetted on the scaffolds into a 96-well plate. The cells 
were incubated at 37°C in a 5% CO2 incubator and monitored 
during 1, 3, 5, and 7 days. The culture medium was changed 
daily. At the end of each day, the PHB samples were placed to 
another culture plate, 200 ml MTT reagent was added to the 
samples. After 4 h incubation in dark, the MTT solution was 
removed and acidic isopropyl alcohol of 200 ml was added to 
24-well plate for dissolving of formazan crystals. After remove 
of samples, the optical density of the solutions in 96-well plate 
was measured using Microplate-Reader at a wavelength of 
570 nm.
Uroepithelial cell morphology on the non-modified 
and modified PHB scaffolds was studied using SEM. 
The scaffolds were fixed with 2.5% glutaraldehyde for 1 
Figure 1. Differential scanning calorimetry thermogram of bacterial PHB. Bacterial PHB with a crystallinity ratio of 59.7% and molecular weight of 
82.500 g/mol is obtained from A. eutrophus strain.
Figure 2. SEM images of the electrospun bacterial PHB nanofiber 
scaffolds. The insets show higher magnification images of the surfaces. 
Bacterial PHB nanofiber scaffolds with a diameter of 700 nm to 800 nm 
are obtained. Scale bars are 30 and 5 mm.
Figure 3. SEM images of synthesized calcium oxalate stones. The insets 
show higher magnification images of the synthesized calcium oxalate 
stones. Calcium oxalate stones show crystal morphology. Scale bars 
are 20 and 200 mm.
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Figure 4. FTIR spectrum of the synthetic calcium oxalate stones. According to the obtained FTIR-spectra, the synthetic calcium oxalate stones 
showed all of the typical bands.
Figure 5. (A) Comparison of water contact angle values for the non-modified and modified PHB scaffolds. (B) Images of the water contact angles 
for the non-modified, EDA- and PEG-modified scaffolds. EDA and PEG plasma treatment enhanced the wettability of bacterial nanofibrillar PHB 
scaffolds. Values are mean  EM; n   5; *p  0.005 compared to the non-modified PHB scaffold.
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Figure 7. Amounts of deposited calcium on the non-modified, EDA- 
and PEG-modified nanofibrillar scaffolds. Calcium oxalate deposition 
decreased on EDA- and PEG-modified PHB scaffolds. Values are 
mean  EM; n  3; statistical significance are marked as * p  0.005, 
** p  0.05.
around 85.97°C and the corresponding melting tempera-
ture was 173.80°C. In concordance with Erceg et al. (2005), 
the melting temperature of PHB was obtained around 
170–180°C. However the percentage of the crystallinity was 
62% for commercial PHB (Chaijamrus and Udpuay 2008). In 
the presented study, the enthalpy of fusion was 87.17 J/g and 
crystallinity ratio of bacterial PHB was calculated as 59.7%. 
Thermal properties of bacterial PHB is compatible with the 
results of the literature. Average molecular weight of bacte-
rial PHB was determined using the viscosimetric measure-
ment and obtained as Mv  82,500 g/mol.
Characterization of bacterial PHB scaffolds
Nanofibrillar bacterial PHB scaffolds were produced by elec-
trospinning, in order to investigate the effect of nanoscaled 
surface properties on the calcium oxalate deposition and cell 
adhesion. Three dimensional, porous, nanofibrillar bacterial 
PHB scaffolds were successfully created using electrospin-
ning method. A porous, non-bead randomly fibrillar structure 
was obtained, which had an average fiber diameter 700–800 
nm (Figure 2). The surface modification of the samples with 
EDA and PEG was performed using radio frequency glow dis-
charge. In our previous work, the surface analysis results of 
PHB scaffolds have been presented and a successfully surface 
treatment was observed according to obtained results.
Synthesis and characterizations of calcium oxalate stones
Structure of synthetic calcium oxalate stones was evaluated 
with SEM. As can be seen in Figure 3, calcium stones indi-
cated typical crystal morphology under electron microscope 
(Ouyang and Deng 2003). Spectroscopic analysis of calcium 
oxalate formation was obtained using FT-IR spectroscopy. 
Figure 4 shows the IR spectrum of the calcium oxalate stones. 
Typical bands for calcium oxalate stones were the strong bands 
around 778.53 (C  O asymmetrical stretching), 1314.93 (C–C 
symmetrical stretching), and 1604.64 (OC  O asymmetrical 
stretching (Channa et al. 2007, Silverstein et al. 2005). In the 
presented study, peaks were obtained at 771.96 cm 1, 1309.96 
cm 1, and 1598.89 cm 1. These values are in good agreement 
with the IR-spectrum for calcium stones in the literature.
Contact angle measurements
Contact angle measurements of non-modified and modified 
samples were conducted to confirm surface functionalization 
(Figure 5A). Initially, non-modified PHB nanofibrillar scaf-
fold indicated a contact angle of 110.5  1.50 that is consistent 
with previous reports (Sombatmankhong et al. 2007). Hydro-
philicity increased dramatically after EDA or PEG modifica-
tions. The dramatic reduction in contact angle attributed to 
the success of plasma treatment. Especially, EDA-modified 
nanofibrillar scaffolds showed a much better wettability 
compared to PEG-modified. The decrease from 110.5  1.50 
to 23  0.5 degree can be attributed to formation of amine 
(-NH2) generated on the surface by the plasma treatment.
Scaffold degradation in-vitro
In vitro degradation of modified and non-modified electro-
spun PHB scaffold was investigated in PBS solution at 37°C 
for a period of 5 weeks. Figure 6 shows the mass changes 
of non-modified and modified bacterial PHB scaffolds. The 
mass loss of the non-modified PHB scaffolds was approxi-
mately 8.08% after 5 weeks while the EDA- and PEG-modi-
fied scaffolds show degradation rate of 12.4 and 10.5% at the 
end of Day 5. After 5-day degradation in PBS, data showed 
no statistically significant difference in related to degrada-
tion rate between non-modified and modified PHB scaf-
folds (p  0.05). Because of theirs degradation properties, 
the modified PHB scaffold is expected to have great poten-
tial applications in medical treatment of bladder failure.
Calcium oxalate deposition of the scaffolds
Alizarin-red staining was used to confirm the amounts 
of deposited calcium oxalate on the scaffolds. The 
Figure 6. In-vitro degradation of non-modified and modified PHB 
scaffolds in PBS solution. There is no statistical difference related 
to degradation rate between groups. Values are mean  EM; n  3; 
statistical significance are marked as *** p  0.05.
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PEG-modified scaffolds exhibit better performance than 
non-modified scaffolds in terms of calcium oxalate inhibi-
tion. In addition to this, amine group existence on the EDA-
modified PHB scaffolds and a slight increase in carbon 
concentration as well as in oxygen concentration on the 
PEG-modified scaffolds demonstrate the success of plasma 
modification.
Additionally, the surface of non-modified and modi-
fied bacterial PHB scaffolds was investigated after 7 days of 
calcium oxalate deposition. Figure 8 shows SEM micrograph 
of samples. Oxalate crystals grown on the non-modifed 
scaffolds are relatively visible. PEG- or EDA-modified scaf-
folds exhibit less stone deposition in comparison to non-
modified scaffolds.
Cell proliferation
Cell viability on the scaffolds was determined using MTT 
mitochondrial activity assay and the results are shown in 
Figure 9. Mouse urinary bladder cells were seeded onto the 
nanoscaffolds. Adhesion and long-term cell growth experi-
ments were performed for 1, 5, 7, and 10 days. The cell pro-
liferation increased with culture time on both non-modified 
and plasma-modified scaffolds. In comparison with non-
modified group, EDA- or PEG-modified nanofibrillar struc-
ture showed much more cell spreading and cell proliferation, 
especially EDA-modified PHB scaffolds. At Day 10, cell num-
bers on the EDA- and PEG-modified scaffolds were signifi-
cantly greater than non-modified (p  0.005). Recent reports 
in the literature suggest that plasma treatment processed 
on the surface enhanced cellular adhesion and spreading 
(Demirbilek et al. 2011, Karahaliloğlu et al. 2012).
The cell morphology and distribution on both non-mod-
ified and plasma modified scaffolds were examined using 
SEM. After 7-day culture, cell images are obtained and shown 
in Figure 10. The images show that cells infiltrated into elec-
trospun PHB matrix and integrated with surrounding fibers. 
Especially, on the EDA- and PEG-modified scaffolds can be 
realized widely distribution of urinary bladder cells on the 
PHB scaffolds, extended of cells along the fibers and genera-
tion of a complex network with surrounding cells.
Discussion
It is well known that nanofibrous scaffolds have many 
advantages for tissue engineering applications. Nano-
absorbance of calcium in all groups increased along 
with the initial concentration, especially in the modified 
groups. As shown in Figure 7, calcium amount on the 
non-modified scaffolds is higher than to modified group 
(EDA or PEG) during assay period. At 5th and 7th days, 
especially at the 7th day, the deposited oxalate amount 
on the EDA- and PEG-modified group decreases. Zhang 
et al. found that double-hydrophilic block copolymer, 
poly(ethyleneglycol)-block-poly(methacrylic acid) (PEG--
b-PMAA) changes the morphology of the calcium oxalate 
dihydrate crystals (Zhang et al. 2002). Further, it has been 
reported that the molecular weight of polyethylene glycol 
is mainly decisive on the inhibition performance of the 
calcium oxalate crystals due to charge and hydrophilic 
effects and the smaller molecular weight of polyethyl-
ene glycol inhibit calcium oxalate crystals more stronger 
(Deng 2007). In addition to that, proteins are known to 
act as inhibitors of crystal growth and nucleation (Pathak 
et al. 2011). Recent studies shown that the inhibition effect 
of amino acids on crystallization increased with increas-
ing of basic –NH2 groups or presence of –OH groups (Yehia 
et al. 2012). The present study suggest that calcium oxalate 
crystals are inhibit through –NH2 or –OH groups gener-
ated after plasma treatment. Accordingly, the growth of 
calcium stones crystals was highly affected by the PEG and 
EDA modifications.
After plasma modification and calcium oxalate treat-
ment, surface chemical composition was determined using 
XPS analysis. The elemental composition and atomic per-
cent of the scaffolds are summarized in Table I. As Alizarin-
red staining test results, XPS results shows that EDA- or 
Figure 8. Calcium oxalate deposition on (A) non-modified, (B) EDA-modified and (C) PEG-modified nanofibrillar PHB scaffolds after 7 days of 
treatment.
Table I. Atomic percentages of C, O, N and Ca elements on the 
non-modified and modified scaffolds. Calcium oxalate deposition 
decreased on EDA- and PEG-modified PHB scaffolds.
Atomic 
percent 
(%) Day 1 Day 3 Day 5 Day 7
Non-modified PHB scaffolds C 68.24 69.71 69.38 68.5
O 29.12 27.67 27.39 28.33
Ca 1.56 0.81 0.79 0.65
EDA-modified PHB scaffolds C 68.64 70.59 70.91 70.04
O 24.22 18.13 19.53 21.40
N 6.02 10.58 8.60 8.44
Ca 1.12 0.70 0.96 0.21
PEG-modified PHB scaffolds C 66.69 66.88 67.84 67.34
O 28.99 28.54 27.01 29.46
Ca 0.87 0.56 0.34 0.11
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structured surface promotes cellular adhesion, prolif-
eration, and regeneration because of the similarity to the 
natural extracellular matrix. Besides this cellular compat-
ibility of nanomaterials, the investigation of nanotextured 
surface is important related to bladder stones formation 
and inhibition for bladder tissue engineering applications. 
For these reasons, the prepared bacterial PHB nanofibri-
lar scaffold was examined for the suitability to be used 
in bladder reconstruction. In order to produce PHB, 
A. eutrophus was grown under in the presence of excess 
carbon source and stepwise purification of PHB was per-
formed, using sodium-hypochlorite and chloroform. A 
polymer crystallinity property of electrospun fibers was 
characterized using DSC. Figure 1 shows that almost 
same crystallinity can be found for both PHB by compar-
ing crystallinity of its commercial counterparts (62%) and 
bacterial PHB (59.7%; Chaijamrus and Udpuay 2008). 
Therefore, it can be said that the bacterial PHB can be 
produced at a reproducible quality and was in the usual 
range of crystallinity value. Average molecular weight of 
bacterial PHB determined using viscosimetric measure-
ment and has a molecular mass of 82,500 g/mol.
Figure 2 shows that is fibrous and highly porous electro-
spun fiber PHB scaffolds. The average size of fiber diameter 
was ranged from 700 to 800 nm. Images were also taken using 
SEM for the visual analysis in order to assess of calcium oxalate 
crystal shape. The characteristic morphology and absorbtion 
bands of oxalate crystals are shown in Figures 3 and 4, respec-
tively. However, it was found that the average size of these 
single crystals is 71.65 mm in length and 23.74 mm in width.
Water contact angle measurements on the non-mod-
ified and modified PHB scaffolds are shown in Figure 5. 
The average contact angle on the non-mofied PHB scaf-
fold was 110.5  1.5°, which was higher than all of the 
modified scaffolds (p  0.05). After plasma treatment, 
the contact angle significantly decreased and the low-
est water contact angle (23.6°) was observed for EDA- 
modified scaffolds. The trend may be attributed to the 
effect of the change in surface chemistry, specifically the 
creation of amine groups on PHB nanofibrilar scaffolds. 
Mutlu et al. reported that the measured contact angles 
of the non-modified and quartz crystal surface modified 
with etylenediamine are 62  5 and 23  4, respectively 
(Mutlu et al. 2008). These results are compatible with the 
measured contact angles on the PHB scaffolds.
In this study, inhibition of the crystal growth is believed to 
be due to modification process because the presence of PEG 
and EDA inhibited the crystal growth of calcium oxalate due 
to the presence of functional groups.
MTT assay results are shown in Figure 9. Modified 
scaffolds exhibited greater cell growth than that of the 
modified PHB scaffolds. Comparing modified and non-
modified scaffolds, the formazan absorbance difference 
EDA- or PEG-modified scaffolds for became even more dis-
tinct (p  0.005) at Day 10. The results indicate that plasma- 
modified scaffolds supported better the cell growth, espe-
cially EDA-modified scaffolds. Figure 10 shows uroepithe-
lial morphology on a neat and modified PHB scaffods after 
7 days. The bladder epithelial cells became elongated after 7 
days of culture and especially, spread well on modified scaf-
folds. The SEM results suggest that bladder epithelial cells are 
able to grow and proliferate well on modified PHB scaffolds.
Conclusions
Based on the reported results, plasma modifications of 
scaffolds were performed successfully as can be seen 
from the results of contact angle experiment. According 
to Alizarin-red staining results, PEG- and EDA-modified 
scaffolds inhibited more crystal growth of calcium oxalate 
compared to non-modified scaffolds. Moreover, results 
of the cell proliferation experiments indicated that EDA-
plasma–modified PHB scaffolds enhanced the cell adhe-
sion and proliferation compared to the non-modified 
and PEG-modified scaffolds. As a conclusion, this study 
Figure 10. SEM images of mouse urinary bladder cells that were cultured on (A) non-modified, (B) EDA-modified and (C) PEG-modified nanofibrous 
PHB scaffolds for 7 days. Scale bars are 100 mm.
Figure 9. Cell attachment of mouse urinary bladder cells on non-
modified and modified PHB scaffolds for 10 days (n  6). Cellular 
proliferation increased on EDA- and PEG-modified PHB scaffolds. 
Statistical significance (p  0.005) are marked as *.
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demonstrated that plasma-modified nanotexture surface 
not only enhanced mouse urinary bladder cell adhesion 
and growth but also reduced the calcium oxalate stone 
formation. Therefore, the prepared modified PHB nanofi-
ber scaffold is a promising candidate for long-term use in 
bladder tissue engineering applications. 
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